Injected Ranibizumab to Treat Macular Telangiectasia Without New Blood Vessel Formation
Clinical trial NCT00457145 · COMPLETED
Trial details
- NCT number
- NCT00457145
- Sponsor
- National Eye Institute (NEI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-27
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.